SB 157 IN
Disclosures related to prescription drugs.
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Summary
Requires certain pharmacists or pharmacies to provide the amount of the national average drug acquisition cost for a generic drug on the written materials provided to an individual at the point of sale of the generic drug.
Sponsors (3)
- Mike Bohacek Republican · author
- Michael Crider Republican · author
- Lori Goss-Reaves Republican · sponsor
3 coauthors / cosponsors
- La Keisha Jackson Democratic · coauthor
- Lonnie Randolph Democratic · coauthor
- Brad Barrett Republican · cosponsor
Action history (13)
- Jan 5, 2026 First reading: referred to Committee on Insurance and Financial Institutions · upper
- Jan 5, 2026 Authored by Senator Bohacek · upper
- Jan 6, 2026 Senator Jackson L added as coauthor · upper
- Jan 15, 2026 Senator Randolph added as coauthor · upper
- Jan 15, 2026 Committee report: amend do pass, adopted · upper
- Jan 22, 2026 Second reading: amended, ordered engrossed · upper
- Jan 22, 2026 Amendment #1 (Bohacek) prevailed; voice vote · upper
- Jan 26, 2026 Third reading: passed; Roll Call 72: yeas 44, nays 0 · upper
- Jan 26, 2026 Senator Crider added as second author · upper
- Jan 26, 2026 House sponsor: Representative Goss-Reaves · upper
- Jan 26, 2026 Cosponsor: Representative Barrett · upper
- Jan 27, 2026 Referred to the House · upper
- Jan 28, 2026 First reading: referred to Committee on Public Health · lower
Subjects
HEALTH; Billing and CostsHEALTH; Prescription Drugs and MedicationsINSURANCE; Health Insurance
Full text
The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.
Comments
Data from OpenStates. View on OpenStates →
Comments